Vasopeptidase inhibitor omapatrilat induces profound insulin sensitization and increases myocardial glucose uptake in zucker fatty rats: studies comparing a vasopeptidase inhibitor, angiotensin-converting enzyme inhibitor, and angiotensin II type I receptor blocker. - Wang,C-H.; Leung,N.; Lapointe,N.; Szeto,L.; Uffelman,KD.; Giacca,A.; Rouleau,JL.; Lewis,GF. (Circulation, 2003)